Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …

Objective To assess the effectiveness of hydroxychloroquine in patients admitted to hospital
with coronavirus disease 2019 (covid-19) pneumonia who require oxygen. Design …

Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals (…

There are no studies which have compared the risk of severe COVID‐19 and related mortality
between transplant recipients and nontransplant patients. We enrolled two groups of …

Background Treatments are urgently needed to prevent respiratory failure and deaths from
coronavirus disease 2019 (COVID-19). Hydroxychloroquine (HCQ) has received worldwide …

Objective To compare individually tailored, based on trimestrial biological parameter
monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of antineutrophil …

Through linkage analysis and candidate gene sequencing, we identified three unrelated
families with the autosomal-dominant inheritance of early onset anemia, hypouricosuric …

Background. Nocardiosis is a rare, life-threatening opportunistic infection, affecting 0.04% to
3.5% of patients after solid organ transplant (SOT). The aim of this study was to identify risk …

A subset of ciliopathies, including Sensenbrenner, Jeune, and short-rib polydactyly syndromes
are characterized by skeletal anomalies accompanied by multiorgan defects such as …

Disorders of the autosomal dominant polycystic kidney disease (ADPKD) spectrum are
characterized by the development of kidney cysts and progressive kidney function decline. PKD1 …